Table 2.
Previous and current treatment.
| Clinical Characteristic | All PsO Patients n = 392 * |
Moderate-Severe PsO n = 252 |
Mild PsO (n = 73) |
p-Value |
|---|---|---|---|---|
| Previous treatment n, (%) | ||||
| Topical | 272 (75.9) | 192 (76.2) | 56 (76.7) | 0.93 |
| Systemic therapy | 69 (19.3) | 53 (21) | 9 (12.3) | 0.13 |
| ≥1 systemic therapy | 115 (32.1) | 103 (40.9) | 7 (9.6) | <0.0001 |
| Biological treatment | 32(8.9) | 26 (10.3) | 5 (6.9) | 0.51 |
| ≥1 biological treatment | 31 (8.7) | 27 (10.7) | 2 (2.7) | 0.06 |
| No previous therapy | 23 (6.4) | 12 (4.8) | 8 (10.9) | 0.09 |
| Current treatment n, (%) | ||||
| Topical | 124 (34.6) | 70 (27.8) | 47 (64.4) | <0.0001 |
| Systemic therapy | 49 (13.7) | 40 (15.9) | 6 (8.2) | 0.14 |
| Biological treatment | 118 (32.9) | 107 (42.5) | 3 (4.1) | <0.0001 |
| No treatment | 61 (17) | 34 (13.5) | 16 (21.9) | 0.12 |
Data presented as number and %. * A total of 67 patients did not know or did not respond to the question regarding “which type of psoriasis were you diagnosed with?”, i.e., missing values. Statistically significant p-values are shown in bold text.